Haptoglobin is present in albumin used as a replacement solution for plasma exchange

Transfusion

Volumn 53, Issue 4, 2013, Pages 757-760

  Cid, Joan ^a   Elena, Montserrat ^a   Diekmann, Fritz ^a   Lozano, Miguel ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; HAPTOGLOBIN;

ARTICLE; CASE REPORT; COMPARTMENT MODEL; CONCENTRATION (PARAMETERS); CRYOGLOBULINEMIA; HUMAN; PLASMAPHERESIS; PROTEIN BLOOD LEVEL; THROMBOTIC THROMBOCYTOPENIC PURPURA; VASCULITIS;

BIOLOGICAL MARKERS; HAPTOGLOBINS; HUMANS; PLASMA EXCHANGE; SERUM ALBUMIN; SOLUTIONS;

EID: 84876112948     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2012.03783.x     Document Type: Article

References (14)

1. Szczepiorkowski ZM, Winters JL, Bandarenko N, Kim HC, Linenberger ML, Marques MB, Sarode R, Schwartz J, Weinstein R, Shaz BH,. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis. J Clin Apher 2010; 25: 83-177.
2. Crookston KP, Novak DJ,. Physiology of apheresis. In:, McLeod BC, Weinstein R, Winters JL, Szczepiorkowski ZM, editors. Apheresis: principles and practice. 3rd ed. Bethesda (MD): American Association of Blood Banks; 2010. p. 45-70.
3. Orlin JB, Berkman EM,. Partial plasma exchange using albumin replacement: removal and recovery of normal plasma constituents. Blood 1980; 56: 1055-9.
4. Kellogg RM, Hester JP,. Kinetics modeling of plasma exchange: intra- and post-plasma exchange. J Clin Apher 1988; 4: 183-7.
5. Weinstein R,. Basic principles of therapeutic blood exchange. In:, McLeod BC, Weinstein R, Winters JL, Szczepiorkowski ZM, editors. Apheresis: principles and practice. 3rd ed. Bethesda (MD): American Association of Blood Banks; 2010. p. 269-94.
6. Petz LD, Garraty G,. Immune hemolytic anemias. 2nd ed. Philadelphia (PA): Churchill Livingstone; 2004. p. 33-60.
7. European Directorate for the Quality of Medicine and Healthcare (EDQM). European pharmacopoeia. 7.0 ed. Strasbourg: EDQM; 2010. p. 2165-6.
8. Dati F, Schumann G, Thomas L, Aguzzi F, Baudner S, Bienvenu J, Blaabjerg O, Blirup-Jensen S, Carlstrom A, Petersen PH, Johnson AM, Milford-Ward A, Ritchie RF, Svendsen PJ, Whicher J,. Consensus of a group of professional societies and diagnostic companies on guidelines for interim reference ranges for 14 proteins in serum based on the standardization against the IFCC/BCR/CAP Reference Material (CRM 470). International Federation of Clinical Chemistry. Community Bureau of Reference of the Commission of the European Communities. College of American Pathologists. Eur J Clin Chem Clin Biochem 1996; 34: 517-20.
9. Cornelissen JJ, Golterman AF, Kerckhaert JA,. Fixed IgM reduction in plasma exchange: a standardized method for calculating the volume to be removed per session. Plasma Ther Transfus Technol 1984; 5: 365-70.
10. Polonovski M, Jayle MF,. Sur la préparation d'une nouvelle fraction des protéines plasmatiques, l'haptoglobin. Comptes Rendues des Séances de la Société de Biologie 1940; 211: 517-9.
11. Maeda N,. Nucleotide sequence of the haptoglobin and haptoglobin-related gene pair. The haptoglobin-related gene contains a retrovirus-like element. J Biol Chem 1985; 260: 6698-709.
12. Carter K, Worwood M,. Haptoglobin: a review of the major allele frequencies worldwide and their association with diseases. Int J Lab Hematol 2007; 29: 92-110.
13. Kasvosve I, Gomo ZA, Gangaidzo IT, Mvundura E, Saungweme T, Moyo VM, Khumalo H, Boelaert JR, Gordeuk VR, Delanghe JR,. Reference range of serum haptoglobin is haptoglobin phenotype-dependent in blacks. Clin Chim Acta 2000; 296: 163-70.
14. Cid MC, Grant DS, Hoffman GS, Auerbach R, Fauci AS, Kleinman HK,. Identification of haptoglobin as an angiogenic factor in sera from patients with systemic vasculitis. J Clin Invest 1993; 91: 977-85.